Paediatric Respiratory Reviews
Volume 10, Issue 3 , Pages 134-142 , September 2009

Update on Cystic Fibrosis-Related Bone Disease: A Special Focus on Children

  • Isabelle Sermet-Gaudelus

      Affiliations

    • Centre de Référence et de Compétence en Mucoviscidose, Hopital Necker-Enfants Malades, INSERM U 845, Université René Descartes, Paris, France
    • ,
  • Mireille Castanet

      Affiliations

    • Service d’Endocrinologie Pédiatrique, Hopital Necker-Enfants Malades, INSERM U 845, Université René Descartes, Paris, France
    • ,
  • George Retsch-Bogart

      Affiliations

    • Division of Pulmonary Medicine, Department of Pediatrics, University of North Carolina, Chapel Hill, NC, USA
    • ,
  • Robert M. Aris

      Affiliations

    • Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of North Carolina, Chapel Hill, NC, USA
    • Corresponding Author InformationCorresponding author.

References 

  1. Rowe S, Miller S, Sorscher EJ. Cystic Fibrosis. N Engl J Med. 2005;352:1992–2001
  2. Mischler EH, Chesney PJ, Chesney RW, Mazess RB. Demineralization in cystic fibrosis detected by direct photon absortiometry. Am J Dis Child. 1979;133:632–635
  3. Conway SP, Morton AM, Oldroyd B, et al. Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors. Thorax. 2000;55:798–804
  4. Aris RM, Merkel PA, Bachrach LK, et al. Consensus conference report : guide to bone health and disease in cystic fibrosis. J Clin Endocr Metabol. 2005;90:1888–1896
  5. Aris RM, Renner JB, Winders AD, et al. Increased fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis. Ann Int Med. 1998;128:186–193
  6. Aris RM, Neuringer IP, Weiner MA, Egan TM, Ontjes D. Severe osteoporosis before and after lung transplantation. Chest. 1996;109:1176–1183
  7. Henderson RC, Madsen CD. Bone mineral content and body composition in children and young adults with cystic fibrosis. Ped Pulmonol. 1999;27:80–84
  8. Haworth CS, Selby PL, Webb AK, et al. Low bone mineral density in adults with cystic fibrosis. Thorax. 1999;54:961–967
  9. Elkin SL, Fairney A, Burnett S, et al. Vertebral deformities and low bone mineral density in adults with cystic fibrosis: a cross-sectional study. Osteoporos Int. 2001;12:366–372
  10. Aris RM, Lester GE, Caminiti M, et al. Efficacy of alendronate in adults with cystic fibrosis with low bone density. Am J Respir Crit Care Med. 2004;169:77–82
  11. Papaioannou A, Kennedy CC, Freitag A, et al. Alendronate once weekly for the prevention and treatment of bone loss in Canadian adult cystic fibrosis patients (CFOS trial). Chest. 2008;134:794–800
  12. Chapman I, Greville H, Ebeling PR, et al. Intravenous zoledronate improves bone density in adults with cystic fibrosis. Clin Endocrinol (Oxf). 2008;Epub ahead of print
  13. Bhudhikanok GS, Lim J, Marcus R, Harkins A, Moss RB, Bachrach LK. Correlates of osteopenia in patients with cystic fibrosis. Pediatrics. 1996;97:103–111
  14. Gronowitz E, Garemo M, Lindblad A, Mellström D, Strandvik B. Decreased bone mineral density in normal-growing patients with cystic fibrosis. Acta Paediatr. 2003;92:688–693
  15. Ujhelyi R, Treszl A, Vasarhelyi B, et al. Bone mineral density acquisition in children and young adults with cystic fibrosis: a follow-up study. J Ped Gastroenterol Nutr. 2004;38:401–406
  16. Bianchi ML, Romano G, Saraifoger S, Costantini D, Limonta C, Colombo C. BMD and body composition in children and young patients affected by cystic fibrosis. J Bone Miner Res. 2006;21:388–396
  17. Sermet-Gaudelus I, Souberbielle JC, Ruiz JC, et al. Low bone mineral density in young children with cystic fibrosis. Am J Respir Crit Car Med. 2007;175:951–957
  18. Grey V, Atkinson S, Drury D, et al. Prevalence of low bone mass and deficiencies of vitamins D and K in pediatric patients with cystic fibrosis from 3 canadian centers. Pediatrics. 2008;122:1014–1020
  19. Laursen EM, Molgaard C, Michaelsen KF, Koch C, Müller J. Bone mineral status in 134 patients with cystic fibrosis. Arch Dis Child. 1999;81:235–240
  20. Mortensen LA, Chan GM, Alder SC, Marshall BC. Bone mineral status in prepubertal children with cystic fibrosis. J Pediatr. 2000;136:648–652
  21. Sood M, Hambleton G, Super M, Fraser WD, Adams JE, Mughal MZ. Bone status in cystic fibrosis. Arch Dis Child. 2001;84:516–520
  22. Hardin DS, Arumugam R, Seilheimer DK, LeBlanc A, Ellis KJ. Normal bone mineral density in cystic fibrosis. Arch Dis Child. 2001;84:363–368
  23. Buntain HM, Greer RM, Schluter PJ, et al. Bone mineral density in australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study. Thorax. 2004;59:149–155
  24. Kelly A, Schall JI, Stallings VA, Zemel BS. Deficits in bone mineral contents in children and adolescents with cystic fibrosis are related to height deficits. J Clin Densitom. 2008;11:581–589
  25. Conway SP, Oldroyd B, Brownlee KG, Truscott JG. A cross-sectional study of bone mineral density in children and adolescents attending a cystic fibrosis centre. J Cyst Fibr. 2008;7:469–476
  26. Rovner AJ, Zemel BS, Leonard MB, Schall JI, Stallings VA. Mild to moderate cystic fibrosis is not associated with increased fracture risk in children and adolescents. J Pediatr. 2005;147:327–331
  27. Buntain HM, Schluter PJ, Bell SC, et al. Controlled longitudinal study of bone mass accrual in children and adolescents with cystic fibrosis. Thorax. 2006;61:146–154
  28. Bhudhikanok GS, Wang MC, Marcus R, Harkins A, Moss RB, Bachrach LK. Bone acquisition and loss in children and adults with cystic fibrosis: a longitudinal study. J Pediatr. 1998;133:18–27
  29. Henderson RC, Madsen C. Bone density in children and adolescents with cystic fibrosis. J Pediatr. 1996;128:28–34
  30. Gronowitz E, Mellström D, Strandvik B. Normal annual increase of bone mineral density during two years in patients with cystic fibrosis. Pediatrics. 2004;114:435–442
  31. Henderson RC, Specter BB. Kyphosis and fractures in children and young adukts with cystic fibrosis. J pediatr. 1994;125:208–212
  32. Bachrach LK, Loutit CW, Moss RB. Osteopenia in adults with cystic fibrosis. Am J Med. 1994;96:27–34
  33. Donovan DS, Papadopoulos A, Staron RB, et al. Bone mass and vitamin D deficiency in adults with advanced Cystic Fibrosis lung disease. Am J Respir Crit Care Med. 1998;157:1892–1899
  34. Papaioannou A, Kennedy CC, Freitag A, et al. Longitudinal analysis of vertebral fracture and BMD in a Canadian cohort of adult cystic fibrosis patients. BMC Musculoskelet Disord. 2008;9:125
  35. Rossini M, Viapiana O, Del Marco A, de Terlizzi F, Gatti D, Adami S. Quantitative ultrasound in adults with cystic fibrosis: correlation with bone mineral density and risk of vertebral fractures. Calcif Tissue Int. 2007;80:44–49
  36. Saggese G, Baroncelli GI, Bertelloni S. Puberty and bone development. Best Pract Res Clin Endocrinol Metab. 2002;16:53–64
  37. Buntain HM, Greer RM, Wong JC, et al. Pubertal development and its influence on bone mineral density in Australian children and adolescents with cystic fibrosis. J Paediatr Child Health. 2005;41:317–322
  38. Byard PJ. The adolescent growth spurt in children with cystic fibrosis. Ann Hum Biol. 1994;21:229–240
  39. Johannesson M, Gottlieb C, Hjelte L. Delayed puberty in girls with cystic fibrosis despite good clinical status. Pediatrics. 1997;99:29–34
  40. Arrigo T, De Luca F, Lucanto C, et al. Nutritional, glycometabolic and genetic factors affecting menarcheal age in cystic fibrosis. Diabetes Nutr Metab. 2004;17:114–119
  41. Jin R, Hodges CA, Drumm ML, Palmert MR. The Cystic fibrosis transmembrane conductance regulator (Cftr) modulates the timing of puberty in mice. J Med Genet. 2006;43:e29
  42. Ionescu AA, Evans WD, Pettit RJ, Nixon LS, Stone MD, Shale DJ. Hidden depletion of fat-free mass and bone mineral density in adults with cystic fibrosis. Chest. 2003;124:2220–2228
  43. Fricke 0, Schoenau E. The “functional mucle-bone unit”: probing the relevance of mechanical signals for bone development in children and adolescents. Growth Horm IGF Res 2007; 17: 1–9.
  44. Kawai M, Rosen CJ. Insulin-like growth factor-I and bone: lessons from mice and men. pediatr Nephrol. 2008;Epub Ahead of Print
  45. Gronowitz E, Mellstrom D, Strandvik B. Serum phospholipids fatty acid pattern is associated with bone mineral density in children, but not adults, with cystic fibrosis. Br J Nutr. 2006;95:1159–1165
  46. Gronowitz E, Lorentzon M, Ohlsson C, Mellström D, Strandvik B. Docosahexaenoic acid is associated with endosteal circumference in long bones in young males with cystic fibrosis. Br J Nutr. 2008;99:160–167
  47. Hind K, Truscott JG, Conway SP. Exercise during childhood and adolescence: a prophylaxis against cystic fibrosis-related low bone mineral density? Exercice for bone health in children with cystic fibrosis. J Cyst Fibr. 2008;7:270–276
  48. Dodd JD, Barry SC, Barry RB, Cawood TJ, McKenna MJ, Gallagher CG. Bone mineral density in cystic fibrosis: benefit of exercise capacity. J Clin Densitom. 2008;11:537–542
  49. Hillman LS, Cassidy JT, Popescu MF, Hewett JE, Kyger J, Robertson JD. Percent true calcium absorption, mineral metabolism, and bone mineralization in children with cystic fibrosis: effect of supplementation with vitamin D and calcium. Pediatr Pulmonol. 2008;43:772–780
  50. Aris RM, Lester GE, Dingman S, Ontjes DA. Altered calcium homeostasis in adults with cystic fibrosis. Osteoporos Int. 1999;10:102–108
  51. Schulze KJ, O’Brien KO, Germain-Lee EL, Baer D, Leonard ALR, Rosenstein BR. Endogenous fecal losses of calcium compromise calcium balance in pancreatic-insufficient girls with cystic fibrosis. J Pediatr. 2003;143:765–771
  52. Turner M, Goldwater D, David J. Oxalate and calcium excretion in cystic fibrosis. Arch Dis Child. 2000;83:244–247
  53. Schulze KJ, Cutchins C, Rosenstein BJ, Germain-Lee EL, O’Brien KO. Calcium acquisition rates do not support age-appropriate gains in total body mineral content in prepuberty and late puberty in girls with cystic fibrosis. Osteoporos Int. 2006;17:731–740
  54. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266–281
  55. Stephenson A, Brotherwood M, Robert R, Atenafu E, Corey M, Tullis E. Cholecalciferol significantly increases 25-dihydroxyvitaminD concentrations in adults with cystic fibrosis. Am J Clin Nutr. 2007;85:1307–1311
  56. Greer RM, Buntain HM, Potter JM, et al. Abnormalities of the PTH-vitamin D axis and bone turnover markers in children, adolescents and adults with cystic fibrosis: comparison with healthy controls. Osteoporos Int. 2003;14:404–411
  57. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311:1770–1773
  58. Wolfenden LL, Judd SE, Shah R, Sanyal R, Ziegler TR, Tangpricha V. Vitamin D and bone health in adults with cystic fibrosis. Clin Endocrinl (Oxf). 2008;69:374–381
  59. Lark RK, Lester GE, Ontjes DA, et al. Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients. Am J Clin Nutr. 2001;73:602–606
  60. Omdahl J, Morris H, May B. Hydroxylase enzymes of the vitamin D pathway: expression, function and regulation. Ann Rev Nutr. 2002;22:139–166
  61. Aris RM, Ontjes DA, Brown DA, Chalermskulrat W, Neuringer I, Lester GE. Carboxylated osteocalcin levels in cystic fibrosis. Am J Respir Crit Care Med. 2003;168:1129
  62. Fewtrell MS, Benden C, Williams JE, et al. Undercarboxylated osteocalcin and bone mass in 8-12 year old children with cystic fibrosis. J Cyst Fibr. 2008;7:307–312
  63. Conway SP, Wolfe SP, Brownlee KG, et al. Vitamin K status among children with cystic fibrosis and its relationship to bone mineral density and bone turnover. Pediatrics. 2005;115:1325–1331
  64. Grey AB, Ames RW, Matthews RD, Reid IR. Bone mineral density and body composition in adult patients with cystic fibrosis. Thorax. 1993;48:589–593
  65. Aris RM, Ontjes DA, Buell HE, et al. Abnormal bone turnover in cystic fibrosis adults. Osteoporos Int. 2002;13:151–157
  66. Aris R, Stephens A, Ontjes D, et al. Adverse alterations in bone metabolism are associated with lung infection in cystic fibrosis adults. Am J Respir Crit Care Med. 2000;162:1674–1678
  67. Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodelling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med. 1995;332:305–311
  68. Jacquot J, Tabary O, Clement A. Hyperinflammation in airways of cystic fibrosis patients: what's new?. Expert Rev Mol Diagn. 2008;8:359–363
  69. Haworth CS, Selby PL, Webb AK, et al. Inflammatory related changes in bone mineral content in adults with cystic fibrosis. Thorax. 2004;59:613–617
  70. Shead EF, Haworth CS, Gunn E, Bilton D, Scott MA, Compston JE. Osteoclastogenesis during infective exacerbations in patients with cystic fibrosis. Am J Respir Crit Care Med. 2006;174:306–311
  71. Aris RM, Lester GE, Renner JB, et al. Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation. Am J Respir Crit Care Med. 2000;162:941–946
  72. Shane E, Papadopoulos A, Staron RB, et al. Bone loss and fracture after lung transplantation. Transplantation. 1999;68:220–227
  73. Dif F, Marty C, Baudoin C, de Vernejoul MC, Levi G. Severe osteopenia in CFTR-null mice. Bone. 2004;35:595–603
  74. Haston CK, Li W, Li A, Lafleur M, Henderson JE. Persistent osteopenia in adult cystic fibrosis transmembrane conductance regulator-deficient mice. Am J Respir Crit Care Med. 2008;177:309–315
  75. Pashuck TD, Franz SE, Altman MK, et al. Murine model for cystic fibrosis bone disease demonstrates osteopenia and sex-related differences in bone formation. Pediatr Res. 2008;Epub Ahead of Print
  76. Shead EF, Haworth CS, Condliffe AM, McKeon DJ, Scott MA, Compston JE. Cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in human bone. Thorax. 2007;62:650–651
  77. Clines GA, Kingsley LA, McKibbin CR, Gabriel SE, Aris RM. CF bone disease: Is mutant CFTR really the culprit?. Ped Pulmonology. 2007;(30 (Suppl)):188–189
  78. Raisz LG. Screening for osteoporosis. N Engl J Med. 2005;353:164–171
  79. Schoenau E, Land C, Stabrey A, Remer T, Kroke A. The bone mass concept: problems in short stature. European J Endocrinol. 2004;151:S87–S91
  80. Fewtrell MS On behalf of the british paediatric and adolescent bone group. Bone densitometry in children assessed by dual x ray absorptiometry: uses and pitfalls. Arch Dis Child. 2003;88:795–798
  81. Sermet-Gaudelus I, Nove-Josserand R, Loeille GA, et al. Recommendations for the management of bone demineralization in cystic fibrosis. Arch Pediatr. 2008;15:301–312
  82. MacKelvie KJ, Petit MA, Khan KM, Beck TJ, McKay HA. Bone mass and structure are enhanced following a 2-year randomised controlled trial of exercise in prepubertal boys. Bone. 2004;34:755–764
  83. Frangolias DD, Paré PD, Kendler DL, Davidson AG, Wong L, Raboud J, et al. Role of exercise and nutrition status on bone mineral density in cystic fibrosis. J Cyst Fibr. 2003;2:163–170
  84. Britto MT, Garrett JM, Konrad TR, Majure JM, Leigh MW. Comparison of physical activity in adolescents with cystic fibrosis versus age-matched controls. Pediatr Pulmonol. 2000;30:86–91
  85. Moshang T, Holsclaw DS. Menarchal determinants in cystic fibrosis. Am J Dis Child. 1980;134:1139–1142
  86. Landon C, Rosenfeld RG. Short stature and pubertal delay in male adolescents with cystic fibrosis. Androgen treatment. Am J Dis Child. 1984;138:388–391
  87. Boyle MP, Noschese ML, Watts SL, Davis ME, Stenner SE, Lechtzin N. Failure of high-dose ergocalciferol to correct vitamin D deficiency in adults with cystic fibrosis. Am J Respir Crit Care Med. 2005;172:212–217
  88. Wanner TJ, Lechtzin N, Davis ME, et al. Very high-dose ergocalciferol is effective for correcting vitamin D deficiency in adults with cystic fibrosis. Ped Pulmonol. 2006;(29 (Suppl)):392
  89. Brown S, Ontjes D, Lark R, et al. Short term calcitriol administration improves calcium homeostasis in adults with CF. Osteoporos Int. 2003;14:442–449
  90. Gronowitz E, Larko O, Gilljam M, et al. Ultraviolet B radiation improves serum levels of vitamin D in patients with cystic fibrosis. Acta Paediatr. 2005;94:547–552
  91. Calcium requirements of infants, children and adolescents. American Academy of Pediatrics. Committee on Nutrition. Pediatrics 1999; 104: 1152–57.
  92. Nicolaidou P, Stavrinadis I, Loukou I, et al. The effect of vitamin K supplementation on biochemical markers of bone formation in children and adolescents with cystic fibrosis. Eur J Pediatr. 2006;165:540–545
  93. Drury D, Grey VL, Ferland G, Gundberg C, Lands LC. Efficacy of high dose phylloquinone in correcting vitamin K deficiency in cystic fibrosis. J Cyst Fibr. 2008;7:457–459
  94. Hardin DS, Ahn C, Prestidge C, Seilheimer DK, Ellis KJ. Growth hormone improves bone mineral content in children with cystic fibrosis. J Pediatr Endocrinol Metab. 2005;18:589–595
  95. Hardin DS, Adams-Huet B, Brown D, et al. Growth hormone treatment improves growth and clinical status in prepubertal children with cystic fibrosis: results of a multicenter randomized controlled trial. J Clin Endocrinol Metab. 2006;91:4925–4929
  96. Glorieux FH, Bishop NJ, Plotkin H, et al. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med. 1998;339:947–952
  97. Haworth CS, Selby PL, Adams JE, Mawer EB, Horrocks AW, Webb AK. Effect of intravenous pamidronate on bone mineral density in adults with cystic fibrosis. Thorax. 2001;56:314–316
  98. Brenckmann C, Papaioannou A, Freitag A, Hennessey R, Hansen S, Ioannidis G, et al. Osteoporosis in Canadian adult cystic fibrosis patients: a descriptive study. BMC Musculoskelet Disord. 2003;4:13

PII: S1526-0542(09)00040-2

doi: 10.1016/j.prrv.2009.05.001

Paediatric Respiratory Reviews
Volume 10, Issue 3 , Pages 134-142 , September 2009

Article Tools

* Image Usage & Resolution